AB SCIEX in antibody analysis agreement

Skip to Navigation

Blog Post

  • Published: Aug 30, 2014
  • Author: Jon Evans
  • Suppliers: AB SCIEX
  • Channels: Laboratory Informatics / HPLC / Ion Chromatography / Gas Chromatography / Electrophoresis / Detectors / Proteomics & Genomics / Sample Preparation

View comments on this post

AB SCIEX has agreed to enter into a research collaboration with Dalton Pharma Services, a Canadian contract manufacturer to the biotechnology and pharmaceutical industries, for the development of antibody-drug conjugate (ADC) analysis capabilities.

This will involve Dalton scientists preparing ADCs and then working with AB SCIEX to develop analytical procedures for characterizing them, including identifying drug loading and the position of conjungation on macromolecules. These analytical procedures will be based on liquid chromatography-mass spectrometry (LC-MS) and will utilize AB SCIEX's TripleTOF MS instruments.

'Recent advances in mass spectrometry have provided a solution to answer the challenging questions in terms of understanding ADC drug development and working within a biological matrix,' said Chris Radloff, vice president, LC/ MS business, at AB SCIEX. 'Utilizing these molecules is difficult and by forming this partnership, ADC developers can now reduce complications, and obtain accurate results that will ultimately lead to safer, more effective therapies.'


There are currently no comments on this post.

Comment Form

You have to log in to comment on this post.

Log in using the form at the top of the page or register here.

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Most Viewed

Copyright Information

Interested in spectroscopy? Visit our sister site spectroscopyNOW.com

Copyright © 2018 John Wiley & Sons, Inc. All Rights Reserved